USPTO serial 88186547
Serial No. 88186547
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 4, 2021
- Examiner
- MARTIN, CHRISTINE C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 88186547?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel R. Mello
Daniel R. Mello Finnegan, Henderson, Farabow, Garrett & Dunner LLP901 New York Avenue NWWashington, DC 20001United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of diseases and disorders, Pharmaceutical preparations for the treatment of cardiac diseases and disorders; Pharmaceutical preparations for the treatment of cardiac diseases and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, and single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation | ACTIVE | — |
| 041 | Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues | ACTIVE | — |
| 042 | Medical and pharmaceutical research for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related thereto for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medical testing services, namely, providing medical testing services and information in the field of the cardiac disease and disorder research, and single ventricle heart disease (SVHD) research, including SVHD subjects who have undergone Fontan Palliation for medical research purposes; conducting clinical trials for others; providing a website featuring medical and scientific research information in the field of pharmaceuticals and medicine | ACTIVE | — |
| 044 | Providing websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues; Medical testing and screening services, namely, medical diagnostic testing services and medical screening for the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease and disorders, and single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mezzion Pharma Co., Ltd.
- Other trademarks owned by Mezzion Pharma Co., Ltd.
- Other trademarks owned by Mezzion Pharma Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 4, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 23, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 23, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 23, 2024 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Aug 23, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 23, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 29, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 29, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 29, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 29, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 29, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 29, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 4, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 16, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 16, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 27, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 14, 2021 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jan 8, 2021 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jan 4, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 28, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 28, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 30, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 30, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 30, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 16, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 16, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 12, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 10, 2020 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Feb 10, 2020 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Feb 10, 2020 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 10, 2020 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 2, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 2, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 2, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 31, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 31, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 29, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 24, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 24, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 28, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 27, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 12, 2018 | NWAP | NEW APPLICATION ENTERED | — |